retatrutide phase 2 trial type 2 diabetes results 2024 π¨Breaking: Retatrutide's first 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No weight loss plateau β curve still descending Retatrutide Results: 28.3% Weight Loss
Description
2021 Mar 30;30(1):32-43
price reductions, Americans often still pay more for GLP-1s than patients in peer nations, particularly for injectable formulations
The set point theory on steroids narrative suggests that any weight loss attempt makes obesity worse through metabolic damage and inevitable overshoot regain
The instrument is a shortened and revised version of the original 51-item TFEQ [24]
